Vetter’s new clinical manufacturing site now officially authorized

0

Vetter Development Service Rankweil receives manufacturing authorization

  • Important milestone reached for the new site
  • Additional filling capacities for early-stage clinical development
  • First customer audits already completed

RAVENSBURG, GERMANY and RANKWEIL, AUSTRIA – Media OutReach – 20 January 2022 – Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site can now support clinical development projects of international pharmaceutical and biotech companies. The service provider had purchased the approximately 10,000 square meters manufacturing facility in 2020.